Načítá se...
Evaluation of the cobas(®) GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures
Direct-acting antiviral (DAA) drug performances depend on the viral genotype. So international recommendations give typing of the virus a prerequisite for treatment choice and patient management. Commercially available HCV genotyping kits are scarce and this analysis is often in-house using tedious...
Uloženo v:
| Vydáno v: | PLoS One |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5864039/ https://ncbi.nlm.nih.gov/pubmed/29566005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194396 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|